수술 중 영상 시장 : 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the intraoperative imaging market size was valued at USD 3.49 billion in 2025 and is estimated to grow from USD 3.75 billion in 2026 to reach USD 5.43 billion by 2031, at a CAGR of 7.65% during the forecast period (2026-2031).

This report is Segmented by Product Type (Mobile C-Arms, Intraoperative Computed Tomography, Intraoperative Magnetic Resonance Imaging, and More), Application (Neurosurgery, Orthopedic and Trauma Surgery, Spine Surgery, and More), End User (Hospitals, Ambulatory Surgical Centers, and More), and Geography (North America, Europe, Asia-Pacific, and Other). The Market Forecasts are Provided in Value (USD)

Global Intraoperative Imaging Market Trends and Insights

Rising Demand for Minimally Invasive Surgery

The shift from open procedures to minimally invasive surgery remains the clearest volume driver for the intraoperative imaging market because surgeons need live imaging when the operative field is smaller and direct visualization is limited. Intuitive Surgical reported 3,153,000 da Vinci procedures in 2025, up 18% from the prior year, and it expects another 13-15% increase in 2026. That growth rate indicates that robotic and image-guided surgical capacity is still expanding faster than many hospital capital replacement cycles. A 2024 study in the Pakistan Journal of Surgical and Neurological Sciences reported that advanced intraoperative imaging reduced neurological complications to 5.3% from 19.1% and bleeding complications to 2.1% from 7.4% when compared with conventional guidance. As hospitals place more weight on measurable outcomes and procedural efficiency, the intraoperative imaging market is likely to see continued demand from centers that want fewer complications, better navigation, and stronger surgeon confidence during technically constrained cases.

AI-Enabled Intraoperative Decision Support

AI is improving the practical value of the intraoperative imaging market by reducing the time between image acquisition and surgical interpretation. A 2026 narrative review reported that Medtronic's FDA-cleared Spine Smart Dose protocol can reduce radiation dose by 70% versus standard O-arm 3D imaging while maintaining navigation accuracy. The same review described the X23D method, which reconstructs a 3D lumbar vertebra model from 4 intraoperative 2D X-rays in 4 seconds, making advanced navigation more accessible in sites without dedicated intraoperative CT suites. Peer reviewed studies cited in that review also showed that MRI-based synthetic CT can support pedicle screw placement safety comparable to conventional CT, which points to a future pathway with less radiation exposure. A 2025 Journal of Clinical Medicine paper further noted that AI, fluorescence, and extended reality are starting to converge into a single guidance layer, which makes AI a workflow enhancer rather than a separate add-on for the intraoperative imaging market.

High Capital and Lifecycle Service Cost

High acquisition and ownership costs remain the most visible barrier in the intraoperative imaging market, especially for modalities at the top end of the capability range. Intraoperative MRI suites can require USD 1-5 million per installation, while O-arm systems typically sit in the USD 750,000-1.2 million range, before service contracts, software licensing, and training are added. These cost layers matter because the buying decision is rarely limited to the scanner alone, and hospitals must account for room design, specialist staffing, maintenance, and downtime exposure. The result is a market where large academic systems can justify premium platforms more easily than mid-tier hospitals, rural buyers, or smaller private groups. This cost gap also favors global OEMs that can spread R&D and service infrastructure over a wider installed base, which keeps the intraoperative imaging market tilted toward scale players in the most advanced product categories.

Other drivers and restraints analyzed in the detailed report include:

1. Hybrid Operating Room Retrofit Cycles in Tertiary Hospitals
2. Expansion of Same-Day Complex Procedures in Ambulatory Settings
3. Reimbursement Pressure on High-Cost Imaging Procedures

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Mobile C-arms held 42.32% of the intraoperative imaging market size in 2025, making them the largest product category by revenue. Their position reflects broad use across orthopedic, trauma, cardiovascular, and general surgery, where hospitals want versatile systems that fit many rooms and case types. Lower capital cost and a smaller physical footprint also make them easier to adopt than fixed systems, especially in facilities that cannot support dedicated CT or MRI suites. This keeps mobile imaging at the center of the intraoperative imaging market, particularly where hospitals are balancing utilization, room flexibility, and replacement budgets.

The rest of the product mix is moving toward tighter software and navigation integration rather than simple hardware upgrades alone. GE HealthCare's April 2026 commercial launch of the bkActiv iUS and Medtronic Stealth AXiS digital link shows how ultrasound is gaining relevance by giving surgeons live intraoperative images alongside pre-operative MRI or CT data during cranial procedures. Intraoperative MRI is projected to grow at 7.78% CAGR through 2031, the fastest pace in the product mix, and IMRIS received FDA 510(k) clearance in August 2025 for its InVision 3T Recharge Operating Suite, which lets hospitals upgrade legacy Siemens Magnetom Verio systems to the AI-integrated Skyra Fit platform without reconstructing the facility. Canon Medical's November 2025 FDA 510(k) clearance for Alphenix 4D CT reinforced the continuing role of intraoperative CT as a strong mid-tier modality inside the intraoperative imaging market.

Complete Report Scope:

• By Product Type
  • Mobile C-Arms
  • Intraoperative Computed Tomography
  • Intraoperative Magnetic Resonance Imaging
  • Intraoperative Ultrasound
  • Others (Intraoperative Endoscopic Imaging Systems and Intraoperative X-ray Systems, among others)
• By Application
  • Neurosurgery
  • Orthopedic and Trauma Surgery
  • Spine Surgery
  • Cardiovascular Surgery
  • Other Applications (Gastrointestinal Surgery and Pediatric Surgery, among others)
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others (Academic & Research Institutes and Specialty Surgical Centers, among others)
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 42.87% of the intraoperative imaging market size in 2025, which kept it as the largest regional contributor. The United States remains the main driver because the FDA clearance flow in 2025 and 2026 covered major platforms from Brainlab, IMRIS, Canon Medical, and Philips across neurosurgery, spine, MRI, CT, and interventional guidance. This product cycle density gives hospitals more upgrade options and supports faster replacement decisions in modalities where software capability is becoming as important as detector or scanner hardware.

Europe remained the second-largest regional base in 2025, supported by mature hospitals, established imaging standards, and demand for advanced surgical workflow tools. Philips launched IntraSight Plus in March 2026 after simultaneous FDA 510(k) clearance and CE marking, which shows that Europe continues to matter as a first-wave commercial region for premium guidance platforms. The region also remains important for AI-enabled navigation and dose management, where recent clinical literature has emphasized better reconstruction speed, lower radiation exposure, and closer integration between imaging and guidance layers. CE marking under the Medical Device Regulation framework supports broader commercialization, but the evidence burden around software and algorithm updates will keep vendor execution discipline high inside the intraoperative imaging market.

Asia-Pacific is projected to grow at 7.73% CAGR through 2031, making it the fastest-growing region in the intraoperative imaging market. The growth profile is broader than in North America because it combines first-time placements in expanding surgical centers with selective uptake of premium systems in high-acuity hospitals. This creates room for both mobile C-arm expansion and longer-term demand for integrated navigation, intraoperative CT, and intraoperative MRI platforms.

1. Activ Surgical, Inc.
2. Allengers
3. Brain Lab
4. Canon
5. Carl Zeiss
6. Esaote S.p.A.
7. FUJIFILM
8. GE Healthcare
9. Hitachi
10. IMRIS, Inc.
11. Koninklijke Philips
12. Medtronic
13. NeuroLogica
14. Samsung Group
15. Shenzhen Anke High-tech Co., Ltd.
16. Mindray
17. Shimadzu
18. Siemens Healthineers
19. Stryker
20. Ziehm Imaging

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Demand for Minimally Invasive Surgery
  • 4.2.2 Wider Use of Real-Time Surgical Navigation and Image Guidance
  • 4.2.3 AI-Enabled Intraoperative Decision Support
  • 4.2.4 Hybrid Operating Room Retrofit Cycles in Tertiary Hospitals
  • 4.2.5 Expansion of Same-Day Complex Procedures in Ambulatory Settings
  • 4.2.6 Increase in the Prevalence of Chronic Diseases
• 4.3 Market Restraints
  • 4.3.1 High Capital and Lifecycle Service Cost
  • 4.3.2 Reimbursement Pressure on High-Cost Imaging Procedures
  • 4.3.3 Sterile Workflow and OR Integration Complexity
  • 4.3.4 Safety Concerns & Regulatory Hurdles
• 4.4 Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bragaining Power of Suppliers
  • 4.7.3 Bragaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Industry Rivalry

5 MARKET SIZE AND GROWTH FORECASTS

• 5.1 By Product Type
  • 5.1.1 Mobile C-Arms
  • 5.1.2 Intraoperative Computed Tomography
  • 5.1.3 Intraoperative Magnetic Resonance Imaging
  • 5.1.4 Intraoperative Ultrasound
  • 5.1.5 Others (Intraoperative Endoscopic Imaging Systems and Intraoperative X-ray Systems, among others)
• 5.2 By Application
  • 5.2.1 Neurosurgery
  • 5.2.2 Orthopedic and Trauma Surgery
  • 5.2.3 Spine Surgery
  • 5.2.4 Cardiovascular Surgery
  • 5.2.5 Other Applications (Gastrointestinal Surgery and Pediatric Surgery, among others)
• 5.3 By End User
  • 5.3.1 Hospitals
  • 5.3.2 Ambulatory Surgical Centers
  • 5.3.3 Clinics
  • 5.3.4 Others (Academic & Research Institutes and Specialty Surgical Centers, among others)
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East & Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.3.1 Activ Surgical, Inc.
  • 6.3.2 Allengers Medical Systems Limited
  • 6.3.3 Brainlab AG
  • 6.3.4 Canon Medical Systems Corporation
  • 6.3.5 Carl Zeiss Meditec AG
  • 6.3.6 Esaote S.p.A.
  • 6.3.7 FUJIFILM Holdings Corporation
  • 6.3.8 GE HealthCare
  • 6.3.9 Hitachi, Ltd.
  • 6.3.10 IMRIS, Inc.
  • 6.3.11 Koninklijke Philips N.V.
  • 6.3.12 Medtronic plc
  • 6.3.13 NeuroLogica Corp.
  • 6.3.14 Samsung Medison Co., Ltd.
  • 6.3.15 Shenzhen Anke High-tech Co., Ltd.
  • 6.3.16 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 6.3.17 Shimadzu Corporation
  • 6.3.18 Siemens Healthineers AG
  • 6.3.19 Stryker
  • 6.3.20 Ziehm Imaging GmbH

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

• 7.1 White-Space and Unmet-Need Assessment